News
The US Food and Drug Administration (FDA) has approved the biologics license application for a subcutaneous formulation of ...
The FDA has approved a supplemental biologics application for Leqembi Iqlik subcutaneous injection for maintenance dosing in ...
TipRanks on MSN4d
Eisai, Biogen initiate rolling BLA to FDA for LEQEMBI
Eisai Co (ESAIY) and Biogen (BIIB) announced that Eisai has initiated the rolling submission of the Supplemental Biologics ...
The once-weekly subcutaneous autoinjector picked up an FDA approval late last week that clears the way for it to be an ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo), for the treatment of adults with advanced Parkinson disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback